Scientific basis for peptide weight loss

Long term studies on GLP-1 agonists have shown that they have beneficial effects in controlling weight and blood sugar. Patients who have been taking GLP-1 agonists for a long time (1 year) have significantly reduced hemoglobin A1c (HbA1c) levels and weight loss.

Studies have also shown that GLP-1 agonists can improve quality of life, reduce cardiovascular risks such as hypertension and weight loss.

Research on sermorelin and ipamorelin has shown that they help with weight loss, improve sleep, energy and endurance, and alleviate symptoms associated with hypogonadism. By increasing growth hormone, sermorelin has been shown to increase lean body mass, insulin sensitivity, and testosterone levels.

Research on Ipamorin has shown that it increases lean muscle mass by increasing insulin release. Researchers believe that the increased growth hormone and insulin levels of ipamolin are the reasons for its weight loss benefits.